These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11910263)

  • 1. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
    Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
    J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
    Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
    Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
    Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
    J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
    McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
    J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
    Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders.
    Jaskiw GE; Thyrum PT; Fuller MA; Arvanitis LA; Yeh C
    Clin Pharmacokinet; 2004; 43(14):1025-35. PubMed ID: 15530131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
    Winter HR; Earley WR; Hamer-Maansson JE; Davis PC; Smith MA
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):81-98. PubMed ID: 18294091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.
    Li Q; Su YA; Liu Y; Chen JX; Tan YL; Yang FD; Si TM
    Clin Pharmacokinet; 2014 May; 53(5):455-65. PubMed ID: 24385309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
    McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
    J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between daily dose, plasma concentrations, dopamine receptor occupancy, and clinical response to quetiapine: a review.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1108-23. PubMed ID: 21294996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine.
    Wong YW; Yeh C; Thyrum PT
    J Clin Psychopharmacol; 2001 Feb; 21(1):89-93. PubMed ID: 11199955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
    J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y; Taner E; Candansayar S
    Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
    Findling RL; Pathak S; Earley WR; Liu S; DelBello M
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):490-501. PubMed ID: 24024534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.